← Eichor
Condition: Dementia Mild Cognitive Impairment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dementia Mild Cognitive Impairment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04335994
Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT07504965
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia)
NA · 1 location(s) · Chung Shan Medical University · NCT06040905
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive
Phase N/A · 1 location(s) · Casa di Cura IGEA · NCT06701630
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Phase N/A · 1 location(s) · Alzheimer's Light LLC · NCT03657745
OCT Angiography and NRAI in Dementia
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03761381
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122
Tennessee Alzheimer's Project
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT05372172
The Swedish BioFINDER - Memory Clinic Study
Phase N/A · 1 location(s) · Skane University Hospital · NCT06122415
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Phase 2 · 1 location(s) · Johns Hopkins University · NCT04601038
Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment
NA · 1 location(s) · City University of Hong Kong · NCT07372066
Optical Neuroimaging and Cognition
Phase N/A · 1 location(s) · University of Cambridge · NCT05460143
Cognitive Screening Made Easy for PCPs - Administrative Supplement
NA · 3 location(s) · University of Texas at Austin · NCT06928298
Early-Stage Partner in Care Living Alone Plus
NA · 1 location(s) · Arizona State University · NCT06962111
Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression
Phase N/A · 1 location(s) · Karolinska Institutet · NCT07629349
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
Phase 1 · 1 location(s) · University of California, San Diego · NCT06548191
Stem Cell Therapy for Early Alzheimer's Disease
Phase 1/Phase 2 · 1 location(s) · Paul E Schulz · NCT06775964
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistic
NA · 1 location(s) · HudsonAlpha Institute for Biotechnology · NCT07146412
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3 · 8 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07083154
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029
Novel Augmentation of DAOIB and Antioxidant for Early Dementia
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06467539
Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort
Phase N/A · 1 location(s) · Korea University · NCT07485387
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Phase 1 · 10 location(s) · Eli Lilly and Company · NCT06297590
ADRC Clinical Cohort (Alzheimer's Disease)
Phase N/A · 1 location(s) · Duke University · NCT06703541
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 143 location(s) · Hoffmann-La Roche · NCT07169578
δ in Dementia Clinical Trials
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05592678
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
NA · 1 location(s) · Rennes University Hospital · NCT06099587
Saliva and Extracellular Vesicles for Neurodegenerative Diseases
Phase N/A · 5 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06869135
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.